#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Wolfram syndrome Dermatomyositis Hereditary ataxia Frontotemporal dementia Measles Stevens-Johnson syndrome White matter lesion Anti-myelin-associated glycoprotein antibodies positive Retinitis pigmentosa Hepatocellular carcinoma Squamous cell carcinoma of the oral cavity Asthma Hereditary neuropathic amyloidosis Obliterative bronchiolitis Endometrial cancer More trials…

    Learn about Rare Diseases

    Castleman’s disease – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Alternating hemiplegia of childhood Factor VIII deficiency – Diagnostics Synovial sarcoma metastatic Hairy cell leukaemia recurrent – Trials in Disease Leiomyosarcoma – Life with Disease Phenylketonuria – Trials in Disease Bronchiolitis obliterans syndrome – Trials in Disease Ewing’s sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZUNIBERGENE ROCPARVOVEC Epinephrine Mb-Cart20.1 Zelicapavir Tryptophan Sodium Sulfate Anhydrous Omp10 Belzupacap Sarotalocan Englumafusp Alfa Vinflunine Lonvoguran Gebasaxturev Exemestane Solrikitug SIPAVIBART IPN01195 Nepafenac Ziltivekimab Dimethyl Fumarate Asp1570 More therapies…

    Learn about Your Condition

    COVID-19 Candida infection Mantle cell lymphoma stage III Chronic lymphocytic leukaemia Pneumonia chlamydial Vaginal haemorrhage Vertigo Polycythaemia vera Colon cancer stage III Fallopian tube cancer stage IV Pelvic venous thrombosis Hypomagnesaemia Adenocarcinoma gastric Lichen planopilaris Vascular dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study on Glucagon and Insulin for Improving Insulin Absorption in Patients with Type 1 Diabetes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Glucagon
    Norway

  • Study on the Safety and Effectiveness of Somapacitan for Children with Short Stature Due to Noonan Syndrome, Turner Syndrome, Small for Gestational Age, or Idiopathic Short Stature

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Noonan syndrome
    • Small for dates baby
    • Turner’s syndrome
    Investigated Drugs:
    • Somapacitan
    The Netherlands Poland Spain

  • Study on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Empagliflozin
    Denmark

  • Study on Metyrapone for Patients with Mild Autonomous Cortisol Secretion Due to Adrenal Adenoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Metyrapone Bp
    Austria

  • Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor negative HER2 positive breast cancer
    • Oestrogen receptor gene overexpression
    • HER2 negative breast cancer
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Ixekizumab
    Sweden
Previous Page
1 … 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!